Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506

Bone Marrow Transplantation

Volumn 21, Issue 1, 1998, Pages 105-109

  Tezcan, H ^a,b   Zimmer, W ^a   Fenstermaker, R ^a   Herzig, G P ^a   Schriber, J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b North Idaho Cancer Center   (United States)

Author keywords

Cerebellar swelling; Cyclosporine neurotoxicity; FK506; Steroids; TTP

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BRAIN EDEMA; CASE REPORT; DRUG MEGADOSE; FEMALE; HODGKIN DISEASE; HUMAN; HYPERTENSION; MALE; NEUROTOXICITY; PATIENT MONITORING; PRIORITY JOURNAL; RADIODIAGNOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0031962541     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701047     Document Type: Article

References (35)

1. Vogelsang G. Pharmacology and use of Immunosuppressive agents after bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, MA, 1994, pp 114-123.
2. Kahan BD. Cyciosporine. New Engl J Med 1989; 321: 1725-1738.
3. Atkinson K, Biggs J, Darveniza P et al. Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 1984; 38: 34-37.
4. Reece DE, Frei-Lahr DA, Shepherd JD et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporine. Bone Marrow Transplant 1991; 8: 393-401.
5. Ghany AM, Tutschka PJ, McGhee RB Jr et al. Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy. Transplantation 1991; 52: 310-315.
6. Erer B, Polchi P, Lucarelli G et al. CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors. Bone Marrow Transplant 1996; 18: 157-162.
7. Spruce WE, Forman SJ, Blume KG et al. Hemolytic uremic syndrome after bone marrow transplantation. Acta Haematol 1982; 67: 206-210.
8. Holler E, Kolb HJ, Miller E et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73: 2018-2024.
9. Johnson PRE, Liu Yin JA, Drayson MT. Thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 7: 321-322.
10. Juckett M, Perry EH, Daniels BS, Weisdorf DJ. Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1991; 7: 405-409.
11. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14: 495-504.
12. Zeigler ZR, Shadduck RK, Nemunaitis J et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995; 15: 247-253.
13. Kalhs P, Brugger S, Schwarzinger I et al. Microangiopathy following allogeneic marrow transplantation. Transplantation 1995; 60: 949-957.
14. Schriber J, Herzig GP. Thrombotic thrombocytopenic purpura (TTP) following bone marrow transplantation. Semin Hematol 1997; 34: 126-133.
15. Schwartz RB, Bravo SM, Klufas RA et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR 1995; 165: 627-631.
16. Dua A, Zeigler ZR, Shadduck RK et al. A prospective study of bone marrow transplant-associated thrombotic microangiopathy in allogeneic BMT and clinical correlates. Blood 1995; 86 (Suppl. 1 ): 866a.
17. Zeigler ZR. Shadduck RK, Nath R, Andrews III DF. Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow transplant-associated thrombotic microangiopathy. Bone Marrow Transplant 1996; 17: 81-86.
18. Zoja C, Furci L, Ghilardi F et al. Cyclosporine-induced endothelial cell injury. Lab Invest 1986; 55: 455-462.
19. Neild GH, Rocchi G, Imberti L et al. Effect of cyclosporine on prostacyclin synthesis by vascular tissue in rabbits. Trans Proc 1983; 4: 2398-2400.
20. Collins P, Wilkie M, Razak K et al. Cyclosporine and crem-aphor modulate von Willebrand factor release from cultured human endothelial cells. Transplantation 1993: 56: 1218-1223.
21. Brown Z, Neild GH. Willoughby JJ et al. Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity. Transplantation 1986; 42: 150-153.
22. Garcia-Maldonado M, Kaufman CE, Comp PC. Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine. Transplantation 1991; 51: 701-705.
23. Carlesen E, Prydz H. Enhancement of procoagulant activity in stimulated mononuclear blood cells and monocytes by cyclosporine. Transplantation 1987; 43: 543-548.
24. Carlsen E, Flatmark A, Prydz H. Cytokine-induced procoagulant activity in monocytes and endothelial cells. Transplantation 1988; 46: 575-580.
25. McCauley J, Bronsther O, Fung J et al. Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet 1989; ii: 1516.
26. Schmidt RJ, Venkat KK, Dumler F. Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. Trans Proc 1991; 23: 3156-3157.
27. Ichihashi T, Naoe T, Yoshida H et al. Haemolytic uraemic syndrome during FK506 therapy. Lancet 1992; 340: 60-61.
28. Gharpure VS, Devine SM, Holland HK et al. Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. Bone Marrow Transplant 1995; 16: 715-716.
29. Zimmer W, Wang H, Schriber J. Cyclosporine A neurotoxicity in allogeneic bone marrow transplantation for hematologic malignancy: magnetic resonance imaging and clinical correlation. Proc Am Soc Neuroradiol 1996; 73 (Abstr.).
30. Pace MT, Slovis TL, Kelly JK, Abella SD. Cyclosporine A toxicity: MRI appearance of the brain. Pediatr Radial 1995; 25: 180-183.
31. Edvinsson L, Owman C, Sjoberg N-O. Autonomic nerves, mast cells, and amine receptors in human brain vessels: histochemical and pharmacologic study. Brain Res 1976; 115: 377-393.
32. Scherrer U, Vissing SF, Morgan BJ et al. Cyclosporin-induced sympathetic activation and hypertension after heart transplantation. New Engl J Med 1990; 323: 693-699.
33. Mark AL. Cyclosporine, sympathetic activity, and hypertension. New Engl J Med 1990; 323: 748-750.
34. Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome. New Engl J Med 1996; 334: 494-500.
35. Nussbaum ES, Maxwell RE, Bitterman PB et al. Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. J Neurosurg 1995; 82: 1068-1070.